Abstract Background Diabetes mellitus type 2 is a common metabolic disorder characterized by an impaired insulin release, an insulin resistance followed by an altered metabolism. The use of plant based… Click to show full abstract
Abstract Background Diabetes mellitus type 2 is a common metabolic disorder characterized by an impaired insulin release, an insulin resistance followed by an altered metabolism. The use of plant based antidiabetic drugs attains an increased importance in recent days due to their potentially reduced side effects. Naregamia alata Wight & Arn. is a small plant extensively referred in Indian traditional medicine to treat various diseases including diabetes. Aim Evaluation of the antidiabetic activity of the methanolic extract (ME) and fractions (petroleum ether (PE), dichloromethane (DCM) and residual methanol (RM)) of N. alata. Methods Determination of the blood glucose, body weight and biochemical parameters (serum) in addition to the evaluation of the free radical generation, liver glycogen content and regeneration of pancreatic β-islets. An attempt was also made to investigate the major classes of phytochemicals responsible for the antidiabetic activity of N. alata. Results The dichloromethane fraction of N. alata showed a significant hypoglycemic effect along with improvements in the body weight (P Conclusion N. alata extracts showed hypoglycemic effect in STZ induced diabetic rats. Further studies to isolate the potent antidiabetic compound(s) and to identify synergistic, antagonistic or additive effects of the active ingredients are under progress.
               
Click one of the above tabs to view related content.